FOI.ICB-2627/103: Hereditary Angioedema (HAE) High-cost-drug (Blueteq) Approvals FOI.ICB-2627/103: Hereditary Angioedema (HAE) High-cost-drug (Blueteq) Approvals Nazwa pliku: FOI.ICB-2627_103-HAE-HIGH-COST-DRUG-BLUETEQ-APPROVALS-FINAL-RESPONSE.PDF Typ pliku: PDF Rozmiar pliku: 250 KB Pobierz